TenderDekho Logo
GEM

Government Tender Published for MDI Glycopyrrolate IP 9mcg, Formoterol Fumerate 4.8mcg & Budesonide IP 160 mcg,MDI Glycopyrrolate I in MUMBAI, MAHARASHTRA

Bid Publish Date

11-Jun-2025, 8:58 am

Bid End Date

03-Jul-2025, 9:00 am

Progress

Issue11-Jun-2025, 8:58 am
Technical07-Jan-2025, 2:10 pm
AwardPending
Explore all 5 tabs to view complete tender details

Quantity

360

Category

MDI Glycopyrrolate IP 9mcg, Formoterol Fumerate 4.8mcg & Budesonide IP 160 mcg

Bid Type

Two Packet Bid

Categories 4

Indian Navy invites bids for MDI Glycopyrrolate IP 9mcg, Formoterol Fumerate 4. 8mcg & Budesonide IP 160 mcg, MDI Glycopyrrolate IP 9mcg & Formoterol Fumerate 4. 8mcg in MUMBAI, MAHARASHTRA. Quantity: 360. Submission Deadline: 03-07-2025 09: 00: 00. Submit your proposal before the deadline.

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Bid To RA Enabled

Yes

Item Category

MDI Glycopyrrolate IP 9mcg, Formoterol Fumerate 4.8mcg & Budesonide IP 160 mcg , MDI Glycopyrrolate IP 9mcg & Formoterol Fumerate 4.8mcg

Authority Records

MINISTRY OF DEFENCEMILITARY AFFAIRS DEPARTMENTINDIAN NAVY

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 4

GeM-Bidding-7777831.pdf

Main Document

Other Documents

OTHER

Other Documents

OTHER

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

OEM Authorization Certificate

5

OEM Annual Turnover

6

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

7

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Technical Results

S.No Seller Item Date Status
1
**********   Under PMA
Make : Zydus Model : FORGLYN PLUS INH CFCFREE 120MDI DC SLDOM Title : MDI Glycopyrrolate IP 9mcg, Formoterol Fumerate 4.8mcg & Budesonide IP 160 mcg01-07-2025 14:10:47

Frequently Asked Questions

Key insights about MAHARASHTRA tender market

What are the eligibility requirements for the MDI Glycopyrrolate IP 9mcg, Formoterol Fumerate 4.8mcg & Budesonide IP 160 mcg tender?

The eligibility requirements include being a registered entity within the pharmaceutical sector. Bidders must also comply with the necessary regulatory approvals and possess experience in supplying similar medical products to government entities. Prior successful deliveries to defense organizations will enhance the application.

What certifications are required to participate in this tender?

Bidders must submit all relevant certificates showing compliance with quality and safety standards. This includes ISO certifications, licensing to operate within the pharmaceutical realm, and any specific certifications related to MDI Glycopyrrolate and its components.

How is the registration process conducted for this tender?

The registration process consists of submitting necessary documentation and complying with the technical and financial requirements. All documentation must be prepared correctly and submitted by the guidelines provided in the tender documentation to ensure acceptance.

What formats are accepted for document submissions in this tender?

Accepted document formats typically include PDF, Word, and any other widely used file types that maintain the integrity of the document. Bidders must avoid obscure formats to ensure that materials can be easily accessed and evaluated.

What kind of financial and performance securities are required for this tender?

Bidders are required to submit an Earnest Money Deposit (EMD), which is refundable after successful contract completion. Additionally, a performance security may be mandated based on the contractual obligations, demonstrating the bidder's commitment to fulfilling the tender requirements efficiently.